Altoida Secures Funding and Research Partnership with Eisai Innovation to Accelerate Work Towards Predictive Dementia Diagnostics

July 7th, 2021 WASHINGTON, D.C., July 7th, 2021 — Altoida, Inc. a pioneer in brain health and leader in the digital biomarkers space, today announced new financing from Eisai Innovation, Inc. (EII), a strategic investment subsidiary of Eisai Inc. Altoida is working internationally to create a new standard in brain health measurement and predictive...